Evolutionary Genomics, Inc. filed its 10-K on Mar 09, 2023 for the period ending Dec 31, 2022. In this report its auditor, Plante & Moran, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 USD | -25.00% | -.--% | -.--% |
2023 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 29.95L | |
+35.14% | 5.15TCr | |
-7.43% | 3.9TCr | |
+34.04% | 3.89TCr | |
-10.62% | 2.67TCr | |
+11.63% | 2.61TCr | |
-17.77% | 1.99TCr | |
+40.52% | 1.37TCr | |
+30.70% | 1.24TCr | |
-3.41% | 1.17TCr |
- Stock Market
- Equities
- FNAM Stock
- News Evolutionary Genomics, Inc.
- Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt